作者：
Vitor,Botafogo [1]
;
Martín,Pérez-Andres [2]
;
María,Jara-Acevedo [3]
;
Paloma,Bárcena [2]
;
Georgiana,Grigore [4]
;
Alejandro,Hernández-Delgado [5]
;
Daniela,Damasceno [2]
;
Suzanne,Comans [6]
;
Elena,Blanco [2]
;
Alfonso,Romero [7]
;
Sonia,Arriba-Méndez [8]
;
Irene,Gastaca-Abasolo [9]
;
Carlos Eduardo,Pedreira [10]
;
Jacqueline A M,van Gaans-van den Brink [11]
;
Véronique,Corbiere [12]
;
Françoise,Mascart [13]
;
Cécile A C M,van Els [11]
;
Alex-Mikael,Barkoff [14]
;
Andrea,Mayado [2]
;
Jacques J M,van Dongen [6]
;
Julia,Almeida [2]
;
Alberto,Orfao [2]
作者单位：
Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.;Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.;Clinical Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
[1]
Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.;Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
[2]
Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.;Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.;Sequencing Service, NUCLEUS, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
[3]
Cytognos SL, Salamanca, Spain.
[4]
Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.;Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.;Cytognos SL, Salamanca, Spain.
[5]
Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, Netherlands.
[6]
Miguel Armijo Primary Health Care Centre, Sanidad de Castilla y León (SACYL), Salamanca, Spain.
[7]
Pediatrics Service, University Hospital of Salamanca, Salamanca, Spain.
[8]
Gynecology and Obstetrics Service, University Hospital of Salamanca, Salamanca, Spain.
[9]
Systems and Computing Department (PESC), COPPE, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
[10]
Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
[11]
Laboratory of Vaccinology and Mucosal Immunity, Université libre de Bruxelles (ULB), Brussels, Belgium.
[12]
Laboratory of Vaccinology and Mucosal Immunity, Université libre de Bruxelles (ULB), Brussels, Belgium.;Immunobiology Clinic, Hôpital Erasme, Brussels, Belgium.
[13]
Institute of Biomedicine, Department of Microbiology, Virology and Immunology, University of Turku (UTU), Turku, Finland.
[14]
主题词
青少年(Adolescent);成年人(Adult);年龄分布(Age Distribution);老年人(Aged);老年人, 80以上(Aged, 80 and over);供血者(Blood Donors);CD4阳性T淋巴细胞(CD4-Positive T-Lymphocytes);儿童(Child);儿童, 学龄前(Child, Preschool);女(雌)性(Female);胎血(Fetal Blood);人类(Humans);免疫表型分型(Immunophenotyping);婴儿(Infant);男(雄)性(Male);中年人(Middle Aged);监测, 免疫学(Monitoring, Immunologic);表型(Phenotype);结果可重复性(Reproducibility of Results);T淋巴细胞, 辅助诱导(T-Lymphocytes, Helper-Inducer);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory);青年人(Young Adult)
DOI
10.3389/fimmu.2020.00166
PMID
32174910
发布时间
2024-07-26
换一批
换一批
